Epigenetic regulation of key vascular genes and growth factors

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 441-446

  Turunen, Mikko P ^a   Ylä Herttuala, Seppo ^b,c  

^a Finland Ark Therapeutics Oy   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Epigenetics; Histone code; KDR; Methylation; Small RNA; VEGF

Indexed keywords

DNA; MATRIX METALLOPROTEINASE; SHORT HAIRPIN RNA; TRANSFER RNA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

CANCER CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE CODE; HISTONE MODIFICATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

ANGIOGENIC PROTEINS; ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; EPIGENESIS, GENETIC; HUMANS; MATRIX METALLOPROTEINASES; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79957451421     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr109     Document Type: Review

References (71)

1. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4: 143-153. (Pubitemid 38198742)
2. Goldberg AD, Allis CD, Bernstein E. Epigenetics: A landscape takes shape. Cell 2007; 128:635-638. (Pubitemid 46273578)
3. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: Basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010;3:567-573.
4. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997;389:251-260. (Pubitemid 27406632)
5. Luger K, Richmond TJ. The histone tails of the nucleosome. Curr Opin Genet Dev 1998; 8:140-146. (Pubitemid 28206276)
6. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-1080. (Pubitemid 32758077)
7. Kouzarides T. Chromatin modifications and their function. Cell 2007;128:693-705. (Pubitemid 46273577)
8. Wolffe AP, Hayes JJ. Chromatin disruption and modification. Nucleic Acids Res 1999; 27:711-720. (Pubitemid 29209356)
9. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74:481-514. (Pubitemid 40995515)
10. Perini G, Diolaiti D, Porro A, Della VG. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA 2005;102: 12117-12122. (Pubitemid 41291138)
11. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem 1998;253:771-777. (Pubitemid 28223547)
12. Prokhortchouk A, Hendrich B, Jorgensen H, Ruzov A, Wilm M, Georgiev G et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 2001;15:1613-1618. (Pubitemid 32702582)
13. Miranda TB, Jones PA. DNA methylation: The nuts and bolts of repression. J Cell Physiol 2007;213:384-390. (Pubitemid 47509717)
14. Smith CL, Peterson CL. A conserved Swi2/Snf2 ATPase motif couples ATP hydrolysis to chromatin remodeling. Mol Cell Biol 2005;25:5880-5892. (Pubitemid 40946545)
15. Polo SE, Almouzni G. Chromatin assembly: A basic recipe with various flavours. Curr Opin Genet Dev 2006;16:104-111. (Pubitemid 43376055)
16. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997;387:43-48. (Pubitemid 27202643)
17. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996;87:953-959. (Pubitemid 26404293)
18. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000;406: 593-599. (Pubitemid 30641039)
19. Bedford MT, Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005;18:263-272. (Pubitemid 41350532)
20. Zhang Y, Reinberg D. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev 2001; 15:2343-2360. (Pubitemid 32899739)
21. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004;119:941-953. (Pubitemid 40037608)
22. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439:811-816. (Pubitemid 43255695)
23. Seward DJ, Cubberley G, Kim S, Schonewald M, Zhang L, Tripet B et al. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat Struct Mol Biol 2007;14:240-242. (Pubitemid 46355570)
24. Karlic R, Chung HR, Lasserre J, Vlahovicek K, Vingron M. Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA 2010;107:2926-2931.
25. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010;28:817-825.
26. Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci USA 2004;101:7357-7362. (Pubitemid 38638037)
27. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442. (Pubitemid 26102720)
28. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000; 127:3941-3946.
29. Shojaei F, Ferrara N. Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab Invest 2007;87:227-230. (Pubitemid 46353946)
30. Folkman J. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 2007;6:273-286. (Pubitemid 46505878)
31. de VC, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
32. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000;60:203-212. (Pubitemid 30070735)
33. Kim JY, Hwang JH, Zhou W, Shin J, Noh SM, Song IS et al. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. Epigenetics 2009;4:313-321.
34. Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R et al. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: A novel example of epigenetherapy. Circ Res 2009;105:604-609.
35. Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab 2010;298:E127-E137.
36. Kang SK, Kang KS, Jee MK, Kim BS. Vascular endothelial growth factor/kinase insult domain receptor (KDR)/fetal liver kinase 1 (FLK1)-mediated skin-epithelial progenitor cells reprogramming. Tissue Eng Part A 2010;16:2687-2697.
37. Buysschaert I, Schmidt T, Roncal C, Carmeliet P, Lambrechts D. Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J Cell Mol Med 2008;12:2533-2551.
38. Xu L, Jain RK. Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma. Mol Cancer Res 2007;5:873-880. (Pubitemid 47416664)
39. Matsumura S, Oue N, Mitani Y, Kitadai Y, Yasui W. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer 2007;120:1689-1695. (Pubitemid 46399355)
40. Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 2008;22:3549-3560.
41. Choi JH, Nam KH, Kim J, Baek MW, Park JE, Park HY et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2404-2409. (Pubitemid 41552662)
42. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010;59:2904-2915.
43. Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 2002;21:427-436. (Pubitemid 34123805)
44. Smits M, Mir SE, Nilsson RJ, van der Stoop PM, Niers JM, Marquez VE et al. Downregulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS ONE 2011;6:e16282.
45. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010;18:185-197.
46. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003;49:1292-1296. (Pubitemid 36900615)
47. Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH et al. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008;102: 933-941. (Pubitemid 351591555)
48. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43:985-991. (Pubitemid 29413198)
49. Kim J, Kim JY, Song KS, Lee YH, Seo JS, Jelinek J et al. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta 2007;1772:72-80. (Pubitemid 44960730)
50. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 2000; 249:101-118.
51. Liu C, Xu D, Sjoberg J, Forsell P, Bjorkholm M, Claesson HE. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 2004; 297:61-67. (Pubitemid 38759562)
52. Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2008; 28:2108-2114.
53. Rodriguez-Salvador J, Armas-Pineda C, Perezpena-Diazconti M, Chico-Ponce de LF, Sosa-Sainz G, Lezama P et al. Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. J Exp Clin Cancer Res 2005;24:463-473. (Pubitemid 41416132)
54. Pender SL, Quinn JJ, Sanderson IR, MacDonald TT. Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. Am J Physiol Gastrointest Liver Physiol 2000; 279:G918-G924.
55. Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005;7:R503-R512.
56. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 2007;3:166-173.
57. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006;103: 17337-17342. (Pubitemid 44788970)
58. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004;305:1289-1292. (Pubitemid 39129233)
59. Weinberg MS, Villeneuve LM, Ehsani A, Amarzguioui M, Aagaard L, Chen ZX et al. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 2006;12:256-262. (Pubitemid 43121930)
60. Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS et al. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 2006;13:787-792. (Pubitemid 44338772)
61. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329: 689-693.
62. Yang K, Zheng XY, Qin J,Wang YB, Bai Y, Mao QQ et al. Up-regulation of p21WAF1/ Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett 2008;265:206-214.
63. Huang V, Qin Y, Wang J, Wang X, Place RF, Lin G et al. RNAa is conserved in mammalian cells. PLoS ONE 2010;5:e8848.
64. Ting AH, Schuebel KE, Herman JG, Baylin SB. Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat Genet 2005;37:906-910. (Pubitemid 41077120)
65. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 2009;28:1708-1719.
66. Mao Q, Li Y, Zheng X, Yang K, Shen H, Qin J et al. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun 2008;375:566-570.
67. Junxia W, Ping G, Yuan H, Lijun Z, Jihong R, Fang L et al. Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. Cancer Sci 2010;101:1790-1796.
68. Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 2008;4:e1000258.
69. Schwartz JC, Younger ST, Nguyen NB, Hardy DB, Monia BP, Corey DR et al. Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 2008;15: 842-848.
70. Ma AN, Huang WL, Wu ZN, Hu JF, Li T, Zhou XJ et al. Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth. Biochem Biophys Res Commun 2010;393:592-597.
71. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 2009;37:2984-2995.